Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
AstraZeneca
McKesson
Farmers Insurance
Healthtrust
Boehringer Ingelheim
Baxter
Deloitte
McKinsey

Generated: September 22, 2018

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: FOSAPREPITANT DIMEGLUMINE

« Back to Dashboard

FOSAPREPITANT DIMEGLUMINE

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Merck And Co Inc EMEND fosaprepitant dimeglumine POWDER;INTRAVENOUS 022023 NDA Merck Sharp & Dohme Corp. 0006-3061-00 1 VIAL, SINGLE-DOSE in 1 CARTON (0006-3061-00) > 5 mL in 1 VIAL, SINGLE-DOSE (0006-3061-01)
Merck And Co Inc EMEND fosaprepitant dimeglumine POWDER;INTRAVENOUS 022023 NDA Merck Sharp & Dohme Corp. 0006-3941-32 1 VIAL, SINGLE-DOSE in 1 CARTON (0006-3941-32) > 5 mL in 1 VIAL, SINGLE-DOSE (0006-3941-01)
Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
Moodys
Johnson and Johnson
Merck
Cantor Fitzgerald
Argus Health
Accenture
QuintilesIMS
Healthtrust